arrow_left Go back to the data side

News on Abbvie.De

81 days ago

There has been 14 news on Abbvie.De in the past from 5 different sources and amongst 2 sections

Latest news

AbbVie shares tumble after schizophrenia drug disappoints
Financial Times link
81 days ago
Stocks making the biggest moves midday: AbbVie, Tesla, Cigna, Morgan Stanley and more
CNBC News link
82 days ago
Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
Quartz link
94 days ago
AbbVie is buying an Alzheimer's drug for more than $1 billion
Quartz link
97 days ago
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz link
282 days ago
Copycats take bite out of AbbVie's best-selling Humira drug
Financial Times link
284 days ago
$19 Billion in a Week: AbbVie Makes Two Big Bets
The Wall Street Journal link
422 days ago
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
CNBC News link
423 days ago
AbbVie to Buy Cerevel Therapeutics for $8.7 Billion
The Wall Street Journal link
424 days ago
AbbVie has agreed to buy biotech ImmunoGen for $10.1 billion in a bet on a promising novel drug technology for attacking cancer.
The Wall Street Journal link
430 days ago
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
CNBC News link
430 days ago
Drugmaker AbbVie to spend over $10 billion on ImmunoGen to juice its cancer-fighting treatment portfolio
Chicago Tribune link
430 days ago

Going further

dataset_white Full dataset

Evolution through time

Sections

The coverage spreads amongst 2 sections:

business 50%
health 36%

Sources

There has been 5 publishers reporting on this, including: The Wall Street Journal (36%), Quartz (21%), CNBC News (21%), Financial Times (14%), Chicago Tribune (7%).

Details

This content can be used under the CC BY 4.0 license